Photo: Patients in the waiting area at Koutiala Hospital in Mali. Mali 2012 © Venetia Dearden
Conference Briefing Paper: Medical Innovations for Neglected PatientsThere are three fundamental problems with medical innovation today. 
First, global public health needs are not in the driving seat. Regardless of how great the needs may be, where commercial potential is weak, there is little “pull” to develop new technologies. The innovation cycle is broken, with few or no incentives for the development of effective, safe, quality, suitable and affordable health technologies—leading to needless suffering and death. 
Second, as a result, developing countries must often “make do” with innovation that primarily caters to conditions in developed countries. Medical tools are too often developed first for developed countries and only rolled out in resource limited settings in a second stage. 
Third, even when there is enough of a profit incentive to drive innovation—for example when diseases affect both developed and developing countries alike—the resulting products are too often priced out of reach. 
Medical innovation must aim to change practice, for the benefit of patients. But ideas, knowledge and inventions can only benefit patients who have access to the fruits of innovation. What is needed, therefore, is not just innovation—but both innovation and access.
Download the full report here.

Photo: Patients in the waiting area at Koutiala Hospital in Mali. Mali 2012 © Venetia Dearden

Conference Briefing Paper: Medical Innovations for Neglected Patients
There are three fundamental problems with medical innovation today. 

First, global public health needs are not in the driving seat. Regardless of how great the needs may be, where commercial potential is weak, there is little “pull” to develop new technologies. The innovation cycle is broken, with few or no incentives for the development of effective, safe, quality, suitable and affordable health technologies—leading to needless suffering and death. 

Second, as a result, developing countries must often “make do” with innovation that primarily caters to conditions in developed countries. Medical tools are too often developed first for developed countries and only rolled out in resource limited settings in a second stage. 

Third, even when there is enough of a profit incentive to drive innovation—for example when diseases affect both developed and developing countries alike—the resulting products are too often priced out of reach. 

Medical innovation must aim to change practice, for the benefit of patients. But ideas, knowledge and inventions can only benefit patients who have access to the fruits of innovation. What is needed, therefore, is not just innovation—but both innovation and access.

Download the full report here.

39 notes

Show

  1. pavementmitosis reblogged this from doctorswithoutborders
  2. lacommunarde reblogged this from doctorswithoutborders
  3. brightfell reblogged this from doctorswithoutborders
  4. fadumamomo reblogged this from doctorswithoutborders and added:
    “Where commercial potential is weak, there is little “pull” to develop new technologies.”Absolutely true and it’s not by...
  5. onthesun18 reblogged this from doctorswithoutborders
  6. idrc-crdi reblogged this from doctorswithoutborders
  7. mikaelaphetamine reblogged this from doctorswithoutborders
  8. ghost-lighting reblogged this from pritheworld
  9. pritheworld reblogged this from doctorswithoutborders
  10. sleepybrains reblogged this from doctorswithoutborders
  11. 40acres1mule reblogged this from doctorswithoutborders
  12. alxndrasplace reblogged this from doctorswithoutborders
  13. kymanijoe21 reblogged this from doctorswithoutborders
  14. gadaboutgreen reblogged this from doctorswithoutborders
  15. music-thestrongestformofmagic reblogged this from doctorswithoutborders
  16. the-electric-boogaloo reblogged this from doctorswithoutborders
  17. doctorswithoutborders posted this